SCHEMBL30438685

SCHEMBL30438685

O=S(=O)(NC(c1ccc(Cl)cc1)C(F)(F)F)c1ccn2ncnc2c1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SCN1A P35498 1/20 0.35
SCN5A Q14524 1/20 0.35
SCN8A Q9UQD0 1/20 0.35
RPS6KB1 P23443 1/20 0.32
CNR1 P21554 2/20 0.32
KDM1A O60341 1/20 0.32
PIK3CD O00329 1/20 0.32
S1PR1 P21453 2/20 0.31
S1PR3 Q99500 1/20 0.31
ALOX5AP P20292 5/20 0.31
FEN1 P39748 5/20 0.31
CYP2C9 P11712 1/20 0.31
IDO1 P14902 1/20 0.31
KCNH2 Q12809 1/20 0.31
THRB P10828 1/20 0.31
CNR2 P34972 1/20 0.30
MGAT2 Q10469 1/20 0.30
F9 P00740 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25703862 1.00 SCN1A (0.35) SCN1ASCN5ASCN8ARPS6KB1CNR1
SCHEMBL25701645 0.90 TGFBR1 (0.38) SCN1ASCN5ASCN8APIK3CDALOX5AP
SCHEMBL30438339 0.90 TGFBR1 (0.38) SCN1ASCN5ASCN8APIK3CDALOX5AP
SCHEMBL31529538 0.89 TEAD1 (0.34) PIK3CDS1PR1
SCHEMBL31294485 0.79 CNR1 (0.36) SCN1ASCN5ASCN8ACNR1KDM1A
SCHEMBL25219722 0.78 SCN1A (0.33) SCN1ASCN5ASCN8ACNR1KDM1A
SCHEMBL30438675 0.78 TP53 (0.36) SCN1ASCN5ASCN8AKDM1AS1PR1
SCHEMBL25268013 0.78 SCN1A (0.33) SCN1ASCN5ASCN8ACNR1KDM1A
SCHEMBL31529503 0.78 TP53 (0.36) SCN1ASCN5ASCN8AKDM1AS1PR1
SCHEMBL30438623 0.77 DPP4 (0.34) CNR1PIK3CDKCNH2F9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4436955-A1 SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL CONDITIONS Lario Therapeutics Limited (GB) 2024-10-02 EP disclosed
WO-2023094830-A1 SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL CONDITIONS LARIO THERAPEUTICS LIMITED (GB) 2023-06-01 WO disclosed